Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.07B | 1.04B | 1.14B | 1.56B | 1.66B | 1.05B | Gross Profit |
255.20M | 243.30M | 238.30M | 269.40M | 292.50M | 178.30M | EBIT |
52.50M | 36.20M | 12.50M | -32.30M | 29.70M | -3.80M | EBITDA |
100.80M | 65.00M | 44.50M | 23.70M | 51.10M | 26.90M | Net Income Common Stockholders |
26.50M | 24.70M | -2.60M | -30.40M | 17.70M | 1.70M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.14M | 40.10M | 19.10M | 19.50M | 67.10M | 6.90M | Total Assets |
36.95M | 441.80M | 460.30M | 549.20M | 615.70M | 449.00M | Total Debt |
1.56M | 70.90M | 95.30M | 153.60M | 95.30M | 106.00M | Net Debt |
-2.59M | 30.80M | 76.20M | 134.10M | 28.20M | 99.10M | Total Liabilities |
25.65M | 304.00M | 354.60M | 476.80M | 519.30M | 369.30M | Stockholders Equity |
11.29M | 137.80M | 105.70M | 73.40M | 97.70M | 80.70M |
Cash Flow | Free Cash Flow | ||||
59.00M | 53.30M | 22.30M | -62.00M | 105.50M | 6.10M | Operating Cash Flow |
67.50M | 61.60M | 24.40M | -52.40M | 114.60M | 14.10M | Investing Cash Flow |
-9.80M | -7.60M | 7.70M | -9.60M | -9.10M | -7.90M | Financing Cash Flow |
-37.00M | -33.00M | -32.30M | 14.40M | -45.30M | -28.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | £1.33B | 6.79 | 2.95% | ― | -10.46% | 396.13% | |
64 Neutral | £825.20M | ― | 890.75% | 0.40% | 5.32% | -152.26% | |
63 Neutral | £575.75M | 22.00 | 20.28% | ― | -0.39% | 2.68% | |
62 Neutral | $6.88B | 11.32 | 2.95% | 3.87% | 2.70% | -24.57% | |
49 Neutral | £379.32M | ― | -62.59% | ― | -15.86% | -18.46% | |
49 Neutral | £363.39M | ― | -27.20% | ― | -14.37% | -28.78% | |
48 Neutral | £268.39M | ― | -96.36% | ― | -16.32% | -202.39% |